U
GSK icon

UBS’s GSK GSK Stock Holding History

UBS’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$60.3M Sell
1,049,670
-247,486
-19% -$15.2M 0.04% 434
2014
Q2 		$86.7M Buy
1,297,156
+7,141
+0.6% +$483K 0.07% 287
2014
Q1 		$86.2M Buy
1,290,015
+21,399
+2% +$1.45M 0.08% 259
2013
Q4 		$84.7M Buy
1,268,616
+58,770
+5% +$3.81M 0.08% 257
2013
Q3 		$75.9M Sell
1,209,846
-53,939
-4% -$3.47M 0.08% 248
2013
Q2 		$78.9M Buy
+1,263,785
New +$80.2M 0.09% 210

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

UBS's GSK Position: Q3 2014 in Review

UBS reduced its GSK (GSK) stake by 19% in Q3 2014, selling an estimated $15.2M and leaving 1,049,670 shares worth $60.3M. The position accounts for 0.04% of the portfolio, ranked #434.

UBS first reported a position in GSK in Q2 2013 and has held it in 6 quarters since. The position peaked at $86.7M in Q2 2014. 701 funds tracked by Wall St. Rank hold GSK as of Q3 2014.

  • UBS held 1,049,670 shares of GSK worth $60.3M as of Q3 2014.
  • UBS sold 247,486 GSK shares in Q3 2014, an estimated $15.2M.
  • GSK made up 0.04% of UBS's portfolio in Q3 2014, its #434 holding.
  • UBS first reported a position in GSK in Q2 2013 and has held it in 6 quarters since.
  • UBS's GSK position peaked at $86.7M in Q2 2014.
  • 701 funds tracked by Wall St. Rank held GSK as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.